Vanda Pharmaceuticals Inc. (VNDA) AI Dilution Summary

Vanda is funding its operations from its balance sheet. Estimated cash was $140,494,000 as of 2026-09-30, the same as cash at the 2026-09-30 balance-sheet date, against estimated monthly burn of $9,478,333. The main driver of potential dilution is the S-3 universal shelf registration (File No. 333-293404).